Lexology February 13, 2020
As promised, here is a summary of some key provisions in CMS’ proposed rule relating to the Medicare Advantage and Part D programs for contract years 2021 and 2022. CMS is soliciting comments on a number of issues and we urge stakeholders to take the opportunity to submit comments. The deadline for comments is April 6, 2020.
The proposed rule has several purposes. First, it implements several statutory requirements including:
- The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (the SUPPORT Act), which requires Part D sponsors to notify CMS of the imposition of a payment suspension on pharmacies that is based on a credible allegation of fraud, impose such payment suspensions...
Today's Sponsors
Today's Sponsor